109 related articles for article (PubMed ID: 30342020)
1. Allosteric regulation of arylamine N-acetyltransferase 1 by adenosine triphosphate.
Minchin RF; Rosengren KJ; Burow R; Butcher NJ
Biochem Pharmacol; 2018 Dec; 158():153-160. PubMed ID: 30342020
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Human Arylamine
Butcher NJ; Burow R; Minchin RF
Mol Pharmacol; 2020 Aug; 98(2):88-95. PubMed ID: 32487734
[TBL] [Abstract][Full Text] [Related]
3. The role of lysine(100) in the binding of acetylcoenzyme A to human arylamine N-acetyltransferase 1: implications for other acetyltransferases.
Minchin RF; Butcher NJ
Biochem Pharmacol; 2015 Apr; 94(3):195-202. PubMed ID: 25660616
[TBL] [Abstract][Full Text] [Related]
4. From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
Laurieri N; Dairou J; Egleton JE; Stanley LA; Russell AJ; Dupret JM; Sim E; Rodrigues-Lima F
PLoS One; 2014; 9(5):e96370. PubMed ID: 24823794
[TBL] [Abstract][Full Text] [Related]
5. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
[TBL] [Abstract][Full Text] [Related]
6. Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?
Rodrigues-Lima F; Dairou J; Busi F; Dupret JM
Curr Drug Targets; 2010 Jun; 11(6):759-66. PubMed ID: 20041842
[TBL] [Abstract][Full Text] [Related]
7. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2008 Oct; 21(10):2005-16. PubMed ID: 18759501
[TBL] [Abstract][Full Text] [Related]
8. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
[TBL] [Abstract][Full Text] [Related]
9. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid.
Butcher NJ; Ilett KF; Minchin RF
Biochem Pharmacol; 2000 Dec; 60(12):1829-36. PubMed ID: 11108798
[TBL] [Abstract][Full Text] [Related]
11. The Bacillus anthracis arylamine N-acetyltransferase ((BACAN)NAT1) that inactivates sulfamethoxazole, reveals unusual structural features compared with the other NAT isoenzymes.
Pluvinage B; Li de la Sierra-Gallay I; Kubiak X; Xu X; Dairou J; Dupret JM; Rodrigues-Lima F
FEBS Lett; 2011 Dec; 585(24):3947-52. PubMed ID: 22062153
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
13. Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis.
Deloménie C; Goodfellow GH; Krishnamoorthy R; Grant DM; Dupret JM
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):207-15. PubMed ID: 9173883
[TBL] [Abstract][Full Text] [Related]
14. A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis.
Sinclair J; Sim E
Biochem Pharmacol; 1997 Jan; 53(1):11-6. PubMed ID: 8960058
[TBL] [Abstract][Full Text] [Related]
15. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
16. Arylamine N-acetyltransferase I.
Minchin RF; Hanna PE; Dupret JM; Wagner CR; Rodrigues-Lima F; Butcher NJ
Int J Biochem Cell Biol; 2007; 39(11):1999-2005. PubMed ID: 17392017
[TBL] [Abstract][Full Text] [Related]
17. Chemical modification of hamster arylamine N-acetyltransferase 2 with isozyme-selective and nonselective N-arylbromoacetamido reagents.
Wang H; Guo Z; Vath GM; Wagner CR; Hanna PE
Protein J; 2004 Feb; 23(2):153-66. PubMed ID: 15106881
[TBL] [Abstract][Full Text] [Related]
18. Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A.
Xu X; Li de la Sierra-Gallay I; Kubiak X; Duval R; Chaffotte AF; Dupret JM; Haouz A; Rodrigues-Lima F
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):266-73. PubMed ID: 25664736
[TBL] [Abstract][Full Text] [Related]
19. Cyanamide-mediated Inhibition of N-acetyltransferase 1.
Dierolf D; Scheitza S; Bonifas J; Blömeke B
Toxicology; 2012 Dec; 302(1):1-10. PubMed ID: 22835378
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells.
Minchin RF
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):1-3. PubMed ID: 7717963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
